Miguel
Alcoceba Sánchez
Investigador desde 2011
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (3)
2020
-
Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
British Journal of Haematology, Vol. 190, Núm. 6, pp. 854-863
2018
-
Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series
Annals of Hematology, Vol. 97, Núm. 12, pp. 2417-2424
2017
-
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group
British Journal of Haematology, Vol. 178, Núm. 5, pp. 699-708